$131.50
-1.05(-0.80%)
Mkt Cap $13.2B
$87.54
$155.63
52-Week Range
At A Glance
1
Neurocrine Biosciences, Inc.
2
Revenue is primarily driven by Product (98.9%) and Collaboration Revenue (1.1%).
3
Most recently: . Results of Operations and Financial Condition. On February 11, 2026, Neurocrine Biosciences, Inc. announced its financial results for the fourth quarter and f (2026-02-11).
$13.2B
Market Cap
$2.9B
Revenue
$483M
Net Income
Employees1,800
Fundamentals
How The Business Makes Money
Revenue by Segment
Product98.9%($7.0B)
Collaboration Revenue1.1%($78M)
Activity
Analyst View
Company Profile
CIK0000914475
ISINUS64125C1099
CUSIP64125C109
Phone858 617 7600
Address12780 El Camino Real, San Diego, CA, 92130, US
SEC EDGAR